Personalized medicine with tyrosine kinase inhibitors: The erlotinib case

P Hartvig-Honoré, K Amin, Anders Mellemgaard

Originalsprog	Engelsk
Tidsskrift	European Journal of Oncology Pharmacy
Vol/bind	7
Udgave nummer	1-2
Sider (fra-til)	32-33
Antal sider	2
ISSN	1783-3914
Status	Udgivet - 2013

Adgang til dokumentet

@article{eb211e6f35444b83a08475d32878cdca,

title = "Personalized medicine with tyrosine kinase inhibitors: The erlotinib case",

author = "P Hartvig-Honor{\'e} and K Amin and Anders Mellemgaard",

year = "2013",

language = "English",

volume = "7",

pages = "32--33",

journal = "European Journal of Oncology Pharmacy",

issn = "1783-3914",

publisher = "Lippincott Williams and Wilkins",

number = "1-2",

}

TY - JOUR

T1 - Personalized medicine with tyrosine kinase inhibitors: The erlotinib case

AU - Hartvig-Honoré, P

AU - Amin, K

AU - Mellemgaard, Anders

PY - 2013

Y1 - 2013

UR - https://www.scopus.com/pages/publications/84886931697

M3 - Journal article

SN - 1783-3914

VL - 7

SP - 32

EP - 33

JO - European Journal of Oncology Pharmacy

JF - European Journal of Oncology Pharmacy

IS - 1-2

ER -